![Robert Kramer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Kramer
Hoofd Techniek/Wetenschap/O&O bij
ALPHA COMPUTE CORP
Vermogen: 1 909 $ op 31-05-2026
Profiel
Robert Alan Kramer was the founder of SalvaRx Group Plc, founded in 2007, where the title held was Chief Scientific Officer.
Current jobs include Director at Phusis Therapeutics, Inc. since 2014, Director at iOx Therapeutics Ltd. since 2022, and Chief Scientific Officer at AlphaTON Capital Corp.
since 2019.
Former jobs include Head-Oncology Discovery Research at Janssen Pharmaceuticals, Inc., Head-Oncology Discovery Research at Bristol-Myers Squibb Pharmaceuticals Ltd., and Assistant Professor at Harvard Medical School.
Education includes a doctorate from the University of Vermont.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ALPHA COMPUTE CORP 0,04% | 21-07-2025 | 5.038 ( 0,04% ) | 1 909 $ | 31-05-2026 |
Actieve functies van Robert Kramer
| Bedrijven | Functie | Begin |
|---|---|---|
| ALPHA COMPUTE CORP | Hoofd Techniek/Wetenschap/O&O | 08-01-2019 |
Phusis Therapeutics, Inc.
 Phusis Therapeutics, Inc. BiotechnologyHealth Technology Develops novel targeted small molecule therapeutics | Directeur/Bestuurslid | 05-05-2014 |
iOx Therapeutics Ltd.
 iOx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops liposomal iNKT agonists | Directeur/Bestuurslid | 15-02-2022 |
Eerdere bekende functies van Robert Kramer
| Bedrijven | Functie | Einde |
|---|---|---|
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Bristol-Myers Squibb Pharmaceuticals Ltd.
 Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | - |
| SALVARX GROUP PLC | Oprichter | - |
Opleiding van Robert Kramer
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
8
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
AlphaTON Capital Corp.
 AlphaTON Capital Corp. Packaged SoftwareTechnology Services Operates as an AI compute infrastructure company that provides hardware-enforced GPU as a service solutions | Technology Services |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Vermont
 University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Phusis Therapeutics, Inc.
Phusis Therapeutics, Inc. BiotechnologyHealth Technology Develops novel targeted small molecule therapeutics | Health Technology |
iOx Therapeutics Ltd.
iOx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops liposomal iNKT agonists | Health Technology |
SalvaRx Group Plc
 SalvaRx Group Plc Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery and development company that focuses on immune-oncology & invests in novel cancer immune-therapies | Commercial Services |
